Login / Signup

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19.

Fasihul A KhanIain D StewartLaura FabbriSamuel MossKaren RobinsonAlan Robert SmythR Gisli Jenkins
Published in: Thorax (2021)
CRD42020176375.
Keyphrases
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • respiratory syndrome coronavirus
  • disease activity
  • systemic lupus erythematosus